Dementia Clinical Trials

Find Dementia Clinical Trials Near You

Cerebral Lactate Uptake and Transport in Obese and Non-Obese Individuals

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY

Cerebral blood flow (CBF) is essential for maintaining brain health and function, as it ensures delivery oxygen and nutrients necessary to support neuronal activity. Reduced CBF can impair the brain's ability to meet its metabolic demands, leading to deficits in cognitive ability. Impairments in CBF are associated with cognitive decline and neurodegenerative disease such as Alzheimer's and dementia. Many factors influence CBF, but recently lactate has emerged as a key player. Blood glucose has long been considered the primary fuel for the brain, but emerging evidence indicates that lactate may be the preferred fuel for neurons, and lactate may become even more important under stressful conditions. Individuals with obesity often have impaired lactate metabolism resulting in higher resting blood lactate concentrations and reduced ability to clear lactate after a physiological stress. At the same time, it is known that exercise is a powerful intervention for improving lactate metabolism. Thus, this project seeks to investigate the role of lactate in brain blood flow in individuals with and without obesity as well as establish if short term exercise training (individuals with obesity only) will alter circulating lactate concentrations at rest and in response to exercise.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:

• healthy adult men and women 18-45 years of age BMI 18-40 kg/m2 not pregnant, premenopausal with regular menstrual cycles not breastfeeding non-nicotine users

Locations
United States
Missouri
University of Missouri
RECRUITING
Columbia
Contact Information
Primary
Matt McDonald, MS
mjmdr4@missouri.edu
6185815501
Backup
Jill Kanaley, PhD
kanaleyj@missouri.edu
5738822519
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2027-03-01
Participants
Target number of participants: 24
Treatments
non-obese
individuals with a BMI\<25 kg/m2
obese
individuals with a BMI 30-40 kg/m2
Related Therapeutic Areas
Sponsors
Leads: University of Missouri-Columbia

This content was sourced from clinicaltrials.gov